Improvement of cardiovascular remodelling by chymase inhibitor.
about
Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.Pharmacological Strategies to Retard Cardiovascular AgingNeprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human KidneyFuture drug discovery in renin-angiotensin-aldosterone system intervention.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.Chymase-dependent production of angiotensin II: an old enzyme in old hearts.
P2860
Improvement of cardiovascular remodelling by chymase inhibitor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Improvement of cardiovascular remodelling by chymase inhibitor.
@en
type
label
Improvement of cardiovascular remodelling by chymase inhibitor.
@en
prefLabel
Improvement of cardiovascular remodelling by chymase inhibitor.
@en
P2860
P356
P1476
Improvement of cardiovascular remodelling by chymase inhibitor.
@en
P2093
Shinji Takai
P2860
P304
P356
10.1111/1440-1681.12549
P577
2016-01-22T00:00:00Z